- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: RRMS,
Total 169 results
-
Novartis PharmaceuticalsNot yet recruitingMultiple Sclerosis, Relapsing-Remitting
-
Novartis PharmaceuticalsTerminated
-
BayerCompleted
-
Scripps HealthWithdrawnMultiple Sclerosis, Relapsing-RemittingUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.Withdrawn
-
Genesis LimitedTerminatedMultiple Sclerosis, Relapsing-RemittingTrinidad and Tobago
-
Novo Cellular Medicine Institute LLPUnknownMultiple Sclerosis, Relapsing-RemittingIndia, Trinidad and Tobago
-
Haukeland University HospitalOslo University Hospital; University Hospital of North Norway; Helse Stavanger... and other collaboratorsActive, not recruitingRelapsing Remitting Multiple SclerosisNorway, Sweden
-
BayerCompleted
-
Novo Cellular Medicine Institute LLPUnknownMultiple Sclerosis, Relapsing-RemittingTrinidad and Tobago
-
Nuron Biotech Inc.UnknownRelapsing Remitting Multiple SclerosisPoland, Spain, Belarus, Bulgaria, Serbia, Ukraine, Russian Federation, Hungary, Italy, Croatia, Georgia, Lebanon
-
Genesis Pharma CNS & SpecialtyCompleted
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisUnited States
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisCzechia, Belgium
-
Novartis PharmaceuticalsCompleted
-
BayerCompletedRelapsing-remitting Multiple SclerosisFrance
-
Haukeland University HospitalPronova BioPharma; The Multiple Sclerosis National Competence Centre; The Norwegian... and other collaboratorsCompleted
-
Queen Mary University of LondonMerck Sharp & Dohme LLCCompletedRelapsing Remitting Multiple SclerosisUnited Kingdom
-
Wayne State UniversityRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
BiogenCompletedRelapsing-Remitting Multiple Sclerosis
-
BiogenCompletedMultiple Sclerosis, Relapsing-RemittingItaly
-
University of CalgaryAlberta Innovates Health SolutionsCompletedMultiple Sclerosis, Relapsing-RemittingCanada
-
University Hospital, Strasbourg, FranceBayer; Grünenthal GmbH; Fédération Hospitalo-Universitaire NEUROGENYCSRecruitingMultiple Sclerosis, Relapsing-RemittingFrance
-
University of MichiganCompleted
-
Novartis PharmaceuticalsCompletedMultiple Sclerosis | RRMSSpain, Czechia, Germany, Australia, Italy, Switzerland, Denmark, United States, United Kingdom, Canada, Netherlands, Poland
-
Immunic AGActive, not recruitingRelapsing-Remitting Multiple Sclerosis (RRMS)Poland, Bulgaria, Romania, Ukraine
-
University Hospital, BordeauxNot yet recruiting
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisCroatia, Bulgaria, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Lithuania, Poland, Belgium, Hungary, Serbia, Finland, Ukraine, Switzerland, Canada, Turkey
-
University at BuffaloWithdrawn
-
MSDx, Inc.CompletedRelapsing Remitting Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple Sclerosis | RRMSRussian Federation, Ukraine, Czech Republic
-
John F. Foley, MDBiogen; Elan PharmaceuticalsCompletedMultiple SclerosisUnited States
-
BiogenElan PharmaceuticalsCompletedRelapsing Remitting Multiple Sclerosis (RRMS)Belgium, Mexico, Poland, Romania, Saudi Arabia, Ukraine
-
BayerCompletedRelapsing Remitting MS (RRMS) | Secondary Progressive MS (SPMS)France, Germany, Korea, Republic of, Saudi Arabia, Spain, Taiwan, Czech Republic, Italy, Jordan, Lebanon, Turkey, Israel, Portugal, Netherlands, Iran, Islamic Republic of
-
NovartisCompletedMultiple SclerosisSwitzerland, Germany, Spain, Portugal, Canada, Denmark, Finland, France, Italy, Poland, United Kingdom
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisBelgium, Bulgaria, Canada, Croatia, Czech Republic, Finland, Germany, Hungary, Italy, Lithuania, Poland, Russian Federation, Serbia, Spain, Turkey, Ukraine, United Kingdom
-
BayerCompletedMultiple SclerosisSwitzerland, France, Germany, Indonesia, Korea, Republic of, Spain, Sweden, Thailand, Taiwan, Australia, Austria, Colombia, Czech Republic, Italy, Jordan, Kazakhstan, Lebanon, Mexico, Slovenia, United Kingdom, Bahrain, Egypt, United... and more
-
Weill Medical College of Cornell UniversityMallinckrodtTerminatedMultiple SclerosisUnited States
-
NovartisCompletedMultiple SclerosisUnited States, Korea, Republic of, Portugal, Canada, Hungary, Spain, Germany, United Kingdom, Australia, Argentina, Austria, Belgium, Brazil, Egypt, France, Greece, Italy, Switzerland
-
Mallinckrodt ARD LLCTerminatedMultiple Sclerosis, Relapsing-RemittingUnited States
-
Aaron BosterPfizer; EMD SeronoCompleted
-
CinnagenCompletedMultiple Sclerosis | Relapsing-RemittingIran, Islamic Republic of
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple SclerosisGermany
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingBelgium, Germany, Russian Federation, Spain, Poland
-
University Hospital, Basel, SwitzerlandNovartisCompletedRelapsing Remitting Multiple SclerosisSwitzerland
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple Sclerosis RRMSGermany, Switzerland
-
Elan PharmaceuticalsTerminatedMultiple SclerosisUnited States, Canada
-
M.D. Anderson Cancer CenterCompletedLeukemia | Systemic MastocytosisUnited States
-
Neurotec PharmaAdvancell - Advanced In Vitro Cell Technologies, S.A.CompletedRelapsing Remitting Multiple SclerosisSpain, Germany
-
BayerCompletedRelapsing Remitting Multiple Sclerosis (RRMS)China, Slovakia, France, Germany, Korea, Republic of, Saudi Arabia, Singapore, Sweden, Taiwan, Colombia, Czech Republic, Estonia, Italy, Jordan, Lebanon, Mexico, Slovenia, United Kingdom, Argentina, Bahrain, Egypt, United Arab Emirates and more